PTC Therapeutics director Alethia Young resigns to focus on other work, stays on as advisor

Filed June 9, 2026 · Period ending June 8, 2026 · ~1 min read

Key Changes

• low

  Board member Alethia Young resigned effective June 8, 2026, citing need to focus on other work commitments. Company states departure was not due to any disagreement.

  Item 5.02 verify on EDGAR →
• low

  Young will continue as paid advisor through June 2027 under consulting agreement paying $4,167 monthly (approximately $50,000 annually).

  Item 5.02 verify on EDGAR →